October 2025 AI in Healthcare & Life Sciences: Strategy, Access & GTM Roundup
This month, we spotlight how AI adoption in healthcare and life sciences is beginning to show tangible outcomes that matter for decision‑makers. Each development reveals where real progress is taking hold, and where informed action can start today. And they all share a clear thread; AI has moved past proof‑of‑concept and is increasingly embedded in the systems that connect discovery, diagnostics, and delivery. Across therapeutic areas, AI systems are now validated by regulators, embedded in enterprise infrastructure, and woven into compliance workflows. For commercial and strategy teams, this creates a new dynamic, not just faster discovery, but shifting economics in how therapies are positioned, priced, and accessed. This roundup filters the noise to focus on the verified developments with the greatest implications for timing, differentiation, and market behavior.
